Harold R Werner's Net Worth

$0

Estimate Recalculated Nov 1, 2024 02:24PM EST

Who is Harold R Werner

Harold R Werner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DIACRIN INC /DE/, TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., HEALTHCARE ACQUISITION CORP, REPLIDYNE INC, TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, CRITICAL THERAPEUTICS INC, MEMORY PHARMACEUTICALS CORP, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, Xencor Inc, LEAP THERAPEUTICS, INC., and GENVEC INC.

SEC CIK

Harold R Werner's CIK is 0001013603

Past Insider Trading and Trends

2007 was Harold R Werner's most active year for acquiring shares with 2 total transactions. Harold R Werner's most active month to acquire stocks was the month of April. 2003 was Harold R Werner's most active year for disposing of shares, totalling 5 transactions. Harold R Werner's most active month to dispose stocks was the month of September. 2003 saw Harold R Werner paying a total of $0.00 for 27,321 shares, this is the most they've acquired in one year. In 2003 Harold R Werner cashed out on 16,768,033 shares for a total of $0.00, their largest year based on trade value.

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TETRALOGIC PHARMACEUTICALS Corp

Investor
Updated Dec 17, 2013
Form 4
-87.88%
-18.75M
$7.00
$6.91M
Dec 17, 2013
2.59M
Buy-Options
Dec 17
Form 3
Dec 11, 2013
Showing 2 results

Radius Health, Inc.

Investor
Updated Dec 23, 2011
Form 4
200.00%
39.30K
$81.42
$3.20M
Dec 23, 2011
58.95K
Purchase
Nov 18 - Dec 14
Form 3
May 24, 2011
83.11K
Showing 2 results

HEALTHCARE ACQUISITION CORP

Investor
Updated Nov 05, 2010
Form 4
$2.54
$2.38M
Nov 05, 2010
4.25M
Options
Nov 03
Form 4
511.65%
928.67K
Jul 30, 2009
1.11M
Acquisition
Jul 28
Form 4/A
2,699.00%
3.37M
$7.66
$957.50K
Nov 13, 2007
3.32M
Purchase
Aug 03
Form 4
2,682.74%
3.35M
$7.66
$957.50K
Aug 07, 2007
3.30M
Purchase
Aug 03
Form 3
Aug 07, 2007
125.00K
Showing 5 results

REPLIDYNE INC

Investor
Updated Jul 06, 2006
Form 4/A
-77.39%
-12.36M
Jul 06, 2006
3.61M
Options
Jul 03
Form 4
-78.12%
-12.36M
Jul 05, 2006
3.46M
Options
Jul 03
Form 3
Jun 27, 2006
Showing 3 results

TREVENA INC

Investor
Updated Feb 07, 2014
Form 4
-81.64%
-10.88M
$7.00
$2.08M
Feb 07, 2014
2.45M
Buy-Options
Feb 05
Form 3
Jan 30, 2014
Showing 2 results

PROTEOSTASIS THERAPEUTICS, INC.

Investor
Updated Feb 17, 2016
Form 4
-84.63%
-11.92M
$8.00
Feb 17, 2016
2.16M
Buy-Options
Feb 17
Form 3
Feb 10, 2016
Showing 2 results

THRESHOLD PHARMACEUTICALS INC

Investor
Updated Oct 07, 2009
Form 4
189.53%
2.79M
Oct 07, 2009
4.26M
Purchase
Oct 05
Form 3
Sep 08, 2008
1.47M
Showing 2 results

GLOBEIMMUNE INC

Investor
Updated Feb 19, 2016
Form 4
-2.63%
-15.00K
$1.44
-$21.60K
Feb 19, 2016
554.27K
Sale
Feb 17 - Feb 19
Form 4
-2.57%
-15.00K
$1.61
-$24.10K
Feb 16, 2016
569.27K
Sale
Feb 11 - Feb 16
Form 3/A
Jul 17, 2014
Form 4
-95.28%
-11.79M
$10.00
$1.90M
Jul 08, 2014
584.27K
Buy-Options
Jul 08
Form 3
Jul 01, 2014
Showing 5 results

CRITICAL THERAPEUTICS INC

Investor
Updated Jul 09, 2004
Form 4/A
-42.52%
-7.07M
$4.20
$6.35M
Jul 09, 2004
9.56M
Buy-Options
Mar 05 - Jun 02
Form 4
-70.76%
-9.82M
$7.00
$2.50M
Jun 02, 2004
4.06M
Buy-Options
Jun 02
Form 3
May 26, 2004
Showing 3 results

MEMORY PHARMACEUTICALS CORP

Investor
Updated Apr 08, 2004
Form 4
-64.22%
-1.44M
Apr 08, 2004
804.75K
Options
Apr 08
Form 3
Apr 05, 2004
58.33K
Showing 2 results

ADVANCIS PHARMACEUTICAL CORP

Investor
Updated Jun 24, 2009
Form 4
20.00K
Jun 24, 2009
20.00K
Grant
Jun 23
Form 4
20.00K
Jun 19, 2008
20.00K
Grant
Jun 04
Form 4
20.00K
May 23, 2007
20.00K
Grant
May 21
Form 4
21.60%
1.20M
$2.36
$2.82M
Apr 13, 2007
6.73M
Purchase
Apr 12
Form 4
14.37%
1.57M
$2.36
$3.72M
Apr 13, 2007
12.54M
Purchase
Apr 12
Form 4
20.00K
May 26, 2006
20.00K
Grant
May 24
Form 4
20.00K
May 27, 2005
20.00K
Grant
May 25
Form 4
25.80%
2.37M
$3.98
$9.45M
May 02, 2005
11.58M
Purchase
Apr 29
Form 4
-45.36%
-4.59M
Oct 23, 2003
5.53M
Options
Oct 22
Form 4
-45.36%
-3.01M
Oct 23, 2003
3.63M
Options
Oct 22
Form 4
-27.52%
-7.61M
Oct 23, 2003
20.03M
Options
Oct 22
Form 4
27.32K
Oct 17, 2003
27.32K
Grant
Oct 16
Form 3
Oct 15, 2003
42.07K
Form 3
Oct 15, 2003
Form 3
Oct 15, 2003
Showing 15 results

DIACRIN INC /DE/

Investor
Updated Aug 22, 2003
Form 4
-100.00%
-291.92K
Aug 22, 2003
Disposition
Aug 21
Form 4
-100.00%
-994.08K
Aug 22, 2003
Disposition
Aug 21
Form 4
-100.00%
-3.20M
Aug 22, 2003
Disposition
Aug 21
Showing 3 results

ACTIVBIOTICS INC

Investor
Updated Aug 07, 2007
Form 4
2,682.74%
3.35M
$7.66
$957.50K
Aug 07, 2007
3.30M
Purchase
Aug 03
Showing 1 results

Xencor Inc

Investor
Updated Dec 06, 2013
Form 4
-67.74%
-2.17M
Dec 06, 2013
1.04M
Options
Dec 06
Form 3
Dec 02, 2013
Showing 2 results

LEAP THERAPEUTICS, INC.

Investor
Updated Aug 01, 2018
Form 4
2.14K
Aug 01, 2018
2.14K
Acq/Dis
Jul 30
Form 3
Jan 23, 2017
2.62M
Showing 2 results

GENVEC INC

Investor
Updated Jun 15, 2007
Form 4
15.00K
Jun 15, 2007
15.00K
Grant
Jun 13
Form 4
-65.68%
-6.85M
$1.25
-$8.57M
Jun 26, 2006
3.58M
Sale
Jun 23
Showing 2 results